Oncología Hepática
University of Tübingen
Tubinga, AlemaniaPublications in collaboration with researchers from University of Tübingen (6)
2023
-
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Journal of Hepatology, Vol. 78, Núm. 4, pp. 794-804
2022
-
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma
Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566
-
Prognostic Factors for Effectiveness Outcomes After Transarterial Radioembolization in Metastatic Colorectal Cancer: Results From the Multicentre Observational Study CIRT
Clinical Colorectal Cancer, Vol. 21, Núm. 4, pp. 285-296
2019
-
Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129](S1359610117301089)(10.1016/j.cytogfr.2017.06.010)
Cytokine and Growth Factor Reviews
-
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Genome Medicine, Vol. 11, Núm. 1
2015
-
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey
Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9